Modulation of gentamicin-induced renal dysfunction and injury by the phenolic extract of soybean (Glycine max)

Martins Ekor1, Ebenezer Olatunde Farombi, Godwin O Emerole

  • 1Department of Biochemistry, Drug Metabolism and Toxicology Unit, University of Ibadan, Ibadan, Nigeria.

Insights

Soybean phenolic extract (PESB) protects against gentamicin (GM)-induced nephrotoxicity in rats. PESB

Area of Science:

  • Pharmacology and Toxicology
  • Natural Product Chemistry
  • Renal Physiology

Background:

  • Gentamicin (GM) is a vital antibiotic for serious infections, but its use is limited by nephrotoxicity.
  • GM-induced kidney damage is linked to oxidative stress, suggesting antioxidants may offer protection.
  • Polyphenolic compounds in soybeans possess antioxidant properties that could mitigate GM-induced renal injury.

Purpose of the Study:

  • To investigate the protective effects of soybean phenolic extract (PESB) against gentamicin-induced nephrotoxicity in a rat model.
  • To evaluate the role of antioxidant properties of PESB in preventing GM-mediated renal damage.
  • To determine the dose-dependent efficacy of PESB in ameliorating kidney injury.

Main Methods:

  • A rat model of gentamicin-induced nephrotoxicity was established using daily subcutaneous injections of GM (80 mg/kg) for 12 days.
  • Rats were pretreated with varying doses of PESB to assess its protective effects.
  • Biochemical markers of renal function (creatinine, urea), oxidative stress (SOD, CAT, GST, GSH), and kidney enzyme activities (G6Pase, 5'-NTD, gamma-GT, AST) were measured.
  • Renal histology was performed to evaluate tubular damage and necrosis.

Main Results:

  • GM administration significantly impaired renal function, increased oxidative stress markers, and altered kidney enzyme activities.
  • Pretreatment with PESB ameliorated GM-induced renal dysfunction and oxidative stress.
  • PESB treatment prevented the decrease in antioxidant enzyme activities and glutathione levels.
  • Histological examination showed reduced tubular necrosis and cast deposition in PESB-treated rats, with a lower dose (500 mg/kg) showing better protection.

Conclusions:

  • Soybean phenolic extract (PESB) demonstrates significant protective effects against gentamicin-induced nephrotoxicity in rats.
  • The nephroprotective action of PESB is likely attributed to its antioxidant polyphenolic constituents.
  • PESB represents a potential therapeutic strategy to mitigate gentamicin-induced kidney damage.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...